The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?
Saved in:
| Title: | The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS? |
|---|---|
| Authors: | Kantarjian H (AUTHOR), O'Brien S (AUTHOR), Ravandi F (AUTHOR), Borthakur G (AUTHOR), Faderl S (AUTHOR), Bueso-Ramos C (AUTHOR), Abruzzo L (AUTHOR), Pierce S (AUTHOR), Shan J (AUTHOR), Issa JP (AUTHOR), Garcia-Manero G (AUTHOR), Kantarjian, Hagop1 (AUTHOR), O'Brien, Susan (AUTHOR), Ravandi, Farhad (AUTHOR), Borthakur, Gautam (AUTHOR), Faderl, Stefan (AUTHOR), Bueso-Ramos, Carlos (AUTHOR), Abruzzo, Lynne (AUTHOR), Pierce, Sherry (AUTHOR), Shan, Jianqin (AUTHOR) |
| Source: | Cancer (0008543X). 11/15/2009, Vol. 115 Issue 22, p5202-5209. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 0008543X |
|---|---|
| DOI: | 10.1002/cncr.24575 |
